Literature DB >> 18573921

The calcium-sensing receptor and insulin secretion: a role outside systemic control 15 years on.

M N Hodgkin1, C E Hills, P E Squires.   

Abstract

In the 15 years since the identification and characterisation of the extracellular calcium-sensing receptor (CaR), it has become increasingly apparent that this cationic binding receptor is found in many tissues, not associated with the control of plasma calcium. One of these tissues is the pancreatic islet where insulin secretion provides the basis of energy regulation. It seems inherently unlikely that the islet responds to alterations in systemic calcium and a more plausible and intriguing possibility is that the CaR mediates cell-to-cell communication through local increases in the concentration of extracellular Ca(2+), co-released with insulin. This short article explores this possibility and suggests that this novel mechanism of cell communication, along with direct coupling via gap junctions and other local paracrine regulators helps explain why the glucose responsiveness of the intact islet is greater than the sum of the composite parts in isolation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18573921     DOI: 10.1677/JOE-08-0261

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Integrating pathway analysis and genetics of gene expression for genome-wide association studies.

Authors:  Hua Zhong; Xia Yang; Lee M Kaplan; Cliona Molony; Eric E Schadt
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

Review 2.  Minireview: Nutrient sensing by G protein-coupled receptors.

Authors:  Eric M Wauson; Andrés Lorente-Rodríguez; Melanie H Cobb
Journal:  Mol Endocrinol       Date:  2013-07-02

Review 3.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

4.  Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).

Authors:  Francesca Giusti; Luisella Cianferotti; Giorgio Gronchi; Federica Cioppi; Laura Masi; Antongiulio Faggiano; Annamaria Colao; Piero Ferolla; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-07-30       Impact factor: 3.633

Review 5.  Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis.

Authors:  Jianzhen Ye; Guangrui Deng; Feng Gao
Journal:  Drug Des Devel Ther       Date:  2018-04-19       Impact factor: 4.162

6.  Hierarchical structural component model for pathway analysis of common variants.

Authors:  Nan Jiang; Sungyoung Lee; Taesung Park
Journal:  BMC Med Genomics       Date:  2020-02-24       Impact factor: 3.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.